RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
TAMPELLINI M
Collezione AOU San Luigi di Orbassano
Items : 49
Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Apr;184:103954. doi: 10.1016/j.critrevonc.2023.103954. Epub 2023 Mar 5.
2023
ASL Città di Torino
ASL Torino 3
AOU San Luigi di Orbassano
Novello S; Tampellini M; Scartozzi M; Manunta S; Solinas C; Denaro N; Aiello MM; Morelli AM; Bertaglia V;
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial. in International journal of cancer / Int J Cancer. 2022 Nov 15;151(10):1760-1769. doi: 10.1002/ijc.34156. Epub 2022 Jun 23.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Morano F; Pietrantonio F; Di Maio M; Di Bartolomeo M; Rossi A; Giordano M; Antonuzzo L; Petrelli F; Ratti M; Berenato R; Clavarezza M; Zaniboni A; Murialdo R; Tampellini M; Fanchini L; Antoniotti C; Bozzarelli S; Sartore-Bianchi A; Lonardi S; Pagani F; Randon G; Prisciandaro M; Raimondi A;
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. in ESMO open / ESMO Open. 2021 Oct;6(5):100246. doi: 10.1016/j.esmoop.2021.100246. Epub 2021 Aug 17.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Di Bartolomeo M; Pietrantonio F; Di Maio M; Morano F; Corallo S; Berenato R; Ratti M; Clavarezza M; Zaniboni A; Murialdo R; Tampellini M; Ritorto G; Raimondi A; Fucà G; Leone AG; Lonardi S; Antoniotti C; Smiroldo V; Amatu A;
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2021 Jul;29(7):3971-3980. doi: 10.1007/s00520-020-05972-2. Epub 2021 Jan 3.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
de Braud F; Di Bartolomeo M; Pietrantonio F; Randon G; Prisciandaro M; Ambrosini M; Pagani F; Niger M; Antista M; Longarini R; Cinieri S; Giordano M; Antonuzzo L; Petrelli F; Toscano G; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Racca P; Amatu A; Rimassa L; Antoniotti C; Morano F; Lonardi S; Corallo S; Raimondi A;
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Feb;144:31-40. doi: 10.1016/j.ejca.2020.11.017. Epub 2020 Dec 13.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Pietrantonio F; Morano F; Calareso G; Di Bartolomeo M; de Braud F; Vaiani M; Greco FG; Prisciandaro M; Pagani F; Palermo F; Raimondi A; Antista M; Clavarezza M; Racca P; Tomasello G; Murialdo R; Tampellini M; Zaniboni A; Smiroldo V; Antoniotti C; Bergamo F; Rimassa L; Lonardi S; Cremolini C; Randon G; Corallo S; Manca P;
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Pietrantonio F; Di Bartolomeo M; Peverelli G; de Braud F; Antista M; Niger M; Bergamo F; Cinieri S; Longarini R; Giordano M; Antonuzzo L; Petrelli F; Adamo V; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Ritorto G; Sartore-Bianchi A; Rimassa L; Antoniotti C; Corallo S; Lonardi S; Morano F; Raimondi A; Di Maio M; Raimondi A; Di Maio M; et alii...
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials. in British journal of cancer / Br J Cancer. 2020 Aug;123(3):403-409. doi: 10.1038/s41416-020-0894-7. Epub 2020 May 19.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Tonini G; Adamo V; Loupakis F; Tomasello G; Zaniboni A; Murialdo R; Boccaccino A; Claravezza M; Bustreo S; Tampellini M; Borelli B; Sartore-Bianchi A; Rimassa L; Lonardi S; Marmorino F; Corallo S; Moretto R; Morano F; Antoniotti C; Guarini V; Fucà G; Cortesi E; de Braud F; Cremolini C; Pietrantonio F; Fucà G; Guarini V; Antoniotti C; Morano F; et alii...
Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. in JAMA oncology / JAMA Oncol. 2019 Sep 1;5(9):1268-1275. doi: 10.1001/jamaoncol.2019.1467.
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Longarini R; Petrelli F; Giordano M; Tomasello G; Adamo V; Zaniboni A; Murialdo R; Smiroldo V; Niger M; Antista M; Caporale M; Berenato R; Clavarezza M; Racca P; Tampellini M; Sartore-Bianchi A; Bergamo F; Rimassa L; Cremolini C; Raimondi A; Lonardi S; Miceli R; Corallo S; Pietrantonio F; Morano F; Cinieri S; Falcone A; Zagonel V; Di Bartolomeo M; et alii...
Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment? in Future oncology (London, England) / Future Oncol. 2018 May;14(12):1223-1231. doi: 10.2217/fon-2017-0627. Epub 2018 Apr 27.
2018
AOU San Luigi di Orbassano
Tampellini M; Bironzo P; Di Maio M; Scagliotti GV;
Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review. in BMC cancer / BMC Cancer. 2018 Mar 20;18(1):311. doi: 10.1186/s12885-018-4205-0.
2018
AOU San Luigi di Orbassano
Brizzi MP; La Salvia A; Tampellini M; Sonetto C; Volante M; Scagliotti GV;
A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:21-29. doi: 10.1016/j.critrevonc.2017.12.010. Epub 2017 Dec 16.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Tampellini M; Scagliotti GV; Brizzi MP; Sonetto C; Di Maio M; Zichi C; Baratelli C;
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients. in Cancers / Cancers (Basel). 2018 Dec 24;11(1):18. doi: 10.3390/cancers11010018.
2018
AOU San Luigi di Orbassano
Campagna S; Sperlinga R; Milo A; Sannuto S; Acquafredda F; Saini A; Gonella S; Berruti A; Scagliotti GV; Tampellini M;
FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report. in BMC cancer / BMC Cancer. 2018 Apr 26;18(1):470. doi: 10.1186/s12885-018-4395-5.
2018
AOU San Luigi di Orbassano
Zichi C; Tampellini M; Tucci M; Sonetto C; Baratelli C; Brizzi MP; Scagliotti GV;
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression. in International journal of clinical oncology / Int J Clin Oncol. 2018 Apr;23(2):281-286. doi: 10.1007/s10147-017-1195-x. Epub 2017 Sep 27.
2018
AOU San Luigi di Orbassano
Baratelli C; Tampellini M; Di Maio M; Ottone A; Brizzi MP; Forti L; Alabiso I; Sonetto C; Alabiso O; Scagliotti GV; Baratelli C; Tampellini M; Di Maio M; Ottone A; Brizzi MP; Forti L; Alabiso I; Sonetto C; Alabiso O; Scagliotti GV;
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
ASL Città di Torino
AOU San Luigi di Orbassano
Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3009-3014. doi: 10.1093/annonc/mdx546.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Fontanini G; Di Maio M; Milione M; Volpi C; Fucà G; Sensi E; Tamburini E; Tampellini M; Baratelli C; Zucchelli G; Busico A; Gloghini A; Rossini D; Perrone F; Tamborini E; Berenato R; Morano F; Moretto R; Cremolini C; De Braud F; Falcone A; Pietrantonio F;
Treatment of Patients With Metastatic Colorectal Cancer in a Real-World Scenario: Probability of Receiving Second and Further Lines of Therapy and Description of Clinical Benefit. in Clinical colorectal cancer / Clin Colorectal Cancer. 2017 Dec;16(4):372-376. doi: 10.1016/j.clcc.2017.03.019. Epub 2017 Apr 8.
2017
AOU San Luigi di Orbassano
La Salvia A; Sonetto C; Brizzi MP; Anania L; Baratelli C; Di Maio M; Tampellini M; Scagliotti GV;
Measuring the Real Clinical Impact of Randomized Clinical Trials in Oncology: Beyond Citation Counts. in JAMA oncology / JAMA Oncol. 2016 Nov 1;2(11):1510-1511. doi: 10.1001/jamaoncol.2016.1779.
2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Tampellini M; Baratelli C; Di Maio M;
Novel investigational therapies for treating biliary tract carcinoma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2016 Dec;25(12):1423-1436. doi: 10.1080/13543784.2016.1252330. Epub 2016
2016
AOU San Luigi di Orbassano
Tampellini M; La Salvia A; Scagliotti GV;
Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy. in La Radiologia medica / Radiol Med. 2016 Dec;121(12):950-957. doi: 10.1007/s11547-016-0685-7. Epub 2016 Sep 6.
2016
AOU San Luigi di Orbassano
Tampellini M; Gned D; Baratelli C; Brizzi MP; Ottone A; Alabiso I; Bertaggia C; Di Maio M; Scagliotti GV; Veltri A;
Novel anti-angiogenic therapeutic strategies in colorectal cancer. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2016;25(5):507-20. doi: 10.1517/13543784.2016.1161754. Epub 2016 Mar 24.
2016
AOU San Luigi di Orbassano
Tampellini M; Sonetto C; Scagliotti GV;
Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature. in BMC cancer / BMC Cancer. 2015 Nov 18;15:914. doi: 10.1186/s12885-015-1923-4.
2015
AOU San Luigi di Orbassano
Brizzi MP; Sonetto C; Tampellini M; Di Maio M; Volante M; Scagliotti GV;
The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2015 Mar;36(3):1519-27. doi: 10.1007/s13277-014-2693-3. Epub 2014 Nov 6.
2015
AOU San Luigi di Orbassano
Tampellini M; Ottone A; Alabiso I; Baratelli C; Forti L; Berruti A; Aroasio E; Scagliotti GV;
Intermittent everolimus administration for malignant insulinoma. in Endocrinology, diabetes & metabolism case reports / Endocrinol Diabetes Metab Case Rep. 2014;2014:140047. doi: 10.1530/EDM-14-0047. Epub 2014 Sep 1.
2014
AOU San Luigi di Orbassano
Baratelli C; Brizzi MP; Tampellini M; Scagliotti GV; Priola A; Terzolo M; Pia A; Berruti A;
Circadian variation of breakthrough pain in cancer patients. in European journal of pain (London, England) / Eur J Pain. 2013 Feb;17(2):264-70. doi: 10.1002/j.1532-2149.2012.00184.x. Epub 2012 Jun 19.
2013
AOU San Luigi di Orbassano
Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A;
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Dec;23(12):3110-3116. doi: 10.1093/annonc/mds148. Epub 2012 Jun 27.
2012
AOU San Luigi di Orbassano
Giacchetti S; Dugué PA; Innominato PF; Bjarnason GA; Focan C; Garufi C; Tumolo S; Coudert B; Iacobelli S; Smaaland R; Tampellini M; Adam R; Moreau T; Lévi F;
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Aug;23(8):2072-2077. doi: 10.1093/annonc/mdr572. Epub 2012 Jan 4.
2012
AOU San Luigi di Orbassano
Santini D; Tampellini M; Vincenzi B; Ibrahim T; Ortega C; Virzi V; Silvestris N; Berardi R; Masini C; Calipari N; Ottaviani D; Catalano V; Badalamenti G; Giannicola R; Fabbri F; Venditti O; Fratto ME; Mazzara C; Latiano TP; Bertolini F; Petrelli F; Ottone A; Caroti C; Salvatore L; Falcone A; Giordani P; Addeo R; Aglietta M; Cascinu S; et alii...
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. in The oncologist / Oncologist. 2012;17(11):1430-8. doi: 10.1634/theoncologist.2012-0142. Epub 2012 Sep 6.
2012
AOU San Luigi di Orbassano
Tampellini M; Ottone A; Bellini E; Alabiso I; Baratelli C; Bitossi R; Brizzi MP; Ferrero A; Sperti E; Leone F; Miraglia S; Forti L; Bertona E; Ardissone F; Berruti A; Alabiso O; Aglietta M; Scagliotti GV;
Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration. in The oncologist / Oncologist. 2012;17(5):645-52. doi: 10.1634/theoncologist.2011-0448. Epub 2012 Apr 20.
2012
AOU San Luigi di Orbassano
Berruti A; Cook R; Saad F; Buttigliero C; Lipton A; Tampellini M; Lee KA; Coleman RE; Smith MR;
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Apr;22(4):988-990. doi: 10.1093/annonc/mdr010. Epub 2011 Feb 14.
2011
AOU San Luigi di Orbassano
Bellini E; Pia A; Brizzi MP; Tampellini M; Torta M; Terzolo M; Dogliotti L; Berruti A;
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010). in Journal of the National Cancer Institute. Monographs / J Natl Cancer Inst Monogr. 2011;2011(43):147-51. doi: 10.1093/jncimonographs/lgr037.
2011
AOU San Luigi di Orbassano
Berruti A; Generali D; Kaufmann M; Puztai L; Curigliano G; Aglietta M; Gianni L; Miller WR; Untch M; Sotiriou C; Daidone M; Conte P; Kennedy D; Damia G; Petronini P; Di Cosimo S; Bruzzi P; Dowsett M; Desmedt C; Mansel RE; Olivetti L; Tondini C; Sapino A; Fenaroli P; Tortora G; Thorne H; Bertolini F; Ferrozzi F; Danova M; et alii...
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2010 Nov;457(5):521-7. doi: 10.1007/s00428-010-0967-8. Epub 2010 Sep 2.
2010
AOU San Luigi di Orbassano
Volante M; Marci V; Andrejevic-Blant S; Tavaglione V; Sculli MC; Tampellini M; Papotti M;
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2009;12(1):94-9. doi: 10.1038/pcan.2008.10. Epub 2008 Mar 11.
2009
AOU San Luigi di Orbassano
Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A;
Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients. in Anticancer research / Anticancer Res. 2008 Sep-Oct;28(5B):3055-60.
2008
AOU San Luigi di Orbassano
Bitossi R; Sculli CM; Tampellini M; Alabiso I; Brizzi MP; Ferrero A; Ottone A; Bellini E; Gorzegno G; Berruti A; Dogliotti L;
Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2007 Oct;133(10):783-5. doi: 10.1007/s00432-007-0234-9. Epub 2007 Jun 6.
2007
AOU San Luigi di Orbassano
Tampellini M; Brizzi MP; Bitossi R; Alabiso I; Sculli CM; Chiusa L; Papotti M; Dogliotti L;
Co-expression of EGF receptor, TGFalpha and S6 kinase is significantly associated with colorectal carcinomas with distant metastases at diagnosis. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2007 Mar;450(3):321-8. doi: 10.1007/s00428-007-0370-2. Epub 2007 Jan 30.
2007
AOU San Luigi di Orbassano
Tampellini M; Longo M; Cappia S; Bacillo E; Alabiso I; Volante M; Dogliotti L; Papotti M;
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. in British journal of cancer / Br J Cancer. 2006 Jul 3;95(1):13-20. doi: 10.1038/sj.bjc.6603204. Epub 2006 Jun 13.
2006
AOU San Luigi di Orbassano
Tampellini M; Saini A; Alabiso I; Bitossi R; Brizzi MP; Sculli CM; Berruti A; Gorzegno G; Magnino A; Sperti E; Miraglia S; Forti L; Alabiso O; Aglietta M; Harris A; Dogliotti L;
Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. in The Lancet. Oncology / Lancet Oncol. 2006 Feb;7(2):186-7. doi: 10.1016/S1470-2045(06)70582-4.
2006
AOU San Luigi di Orbassano
Saini A; Berruti A; Sperone P; Bitossi R; Tampellini M; Dogliotti L; Gorzegno G;
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2006 Aug;98(3):241-8. doi: 10.1007/s10549-005-9155-y. Epub 2006 May 3.
2006
AOU San Luigi di Orbassano
Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L;
Stage IB malignant thymoma in a Lynch syndrome patient with multiple cancers: response to incidental administration of oxaliplatin and 5-fluorouracil. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2006 Aug;18(4):433-6. doi: 10.1179/joc.2006.18.4.433.
2006
AOU San Luigi di Orbassano
Tampellini M; Alabiso I; Sculli CM; Barberis M; Giachino D; Berruti A; Dogliotti L;
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. in British journal of cancer / Br J Cancer. 2005 Sep 19;93(6):633-8. doi: 10.1038/sj.bjc.6602767.
2005
AOU San Luigi di Orbassano
Berruti A; Tucci M; Mosca A; Tarabuzzi R; Gorzegno G; Terrone C; Vana F; Lamanna G; Tampellini M; Porpiglia F; Angeli A; Scarpa RM; Dogliotti L;
Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients. in Anticancer research / Anticancer Res. 2005 Nov-Dec;25(6C):4475-9.
2005
AOU San Luigi di Orbassano
Berruti A; Mosca A; Bitossi R; Gorzegno G; Guercio S; Poggio M; Tampellini M; Porpiglia F; Ostellino O; Scarpa RM; Dogliotti L;
Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial. in Endocrine-related cancer / Endocr Relat Cancer. 2005 Jun;12(2):383-92. doi: 10.1677/erc.1.00945.
2005
AOU San Luigi di Orbassano
Bottini A; Berruti A; Brizzi MP; Bersiga A; Generali D; Allevi G; Aguggini S; Bolsi G; Bonardi S; Tondelli B; Vana F; Tampellini M; Alquati P; Dogliotti L;
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up. in Urologic oncology / Urol Oncol. 2005 Jan-Feb;23(1):1-7. doi: 10.1016/j.urolonc.2004.06.003.
2005
AOU San Luigi di Orbassano
Berruti A; Fara E; Tucci M; Tarabuzzi R; Mosca A; Terrone C; Gorzegno G; Fasolis G; Tampellini M; Porpiglia F; De Stefanis M; Fontana D; Bertetto O; Dogliotti L;
Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization study. in Tumori / Tumori. 2004 Jan-Feb;90(1):44-9. doi: 10.1177/030089160409000111.
2004
AOU San Luigi di Orbassano
Tampellini M; Bitossi R; Brizzi MP; Saini A; Tucci M; Alabiso I; Dogliotti L;
Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases. in The International journal of biological markers / Int J Biol Markers. 2002 Oct-Dec;17(4):244-52. doi: 10.5301/jbm.2008.2194.
2002
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Tucci M; Tarabuzzi R; Guercio S; Torta M; Tampellini M; Dovio A; Poggio M; Scarpa RM; Angeli A;
Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2001 Nov-Dec;22(6):367-73. doi: 10.1159/000050639.
2001
AOU San Luigi di Orbassano
Tampellini M; Berruti A; Gorzegno G; Bitossi R; Bottini A; Durando A; De Matteis A; Farris A; Donadio M; De Fabiani E; Manzin E; Arese P; Sarobba MG; Castiglione F; Moro G; Bonazzi G; Nuzzo F; Massobrio M; Dogliotti L;
Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases. in Clinical chemistry / Clin Chem. 1999 Aug;45(8 Pt 1):1240-7.
1999
AOU San Luigi di Orbassano
Berruti A; Dogliotti L; Gorzegno G; Torta M; Tampellini M; Tucci M; Cerutti S; Frezet MM; Stivanello M; Sacchetto G; Angeli A;
Hypertriglyceridemia during long-term interferon-alpha therapy: efficacy of diet and gemfibrosil treatment. A case report. in Tumori / Tumori. 1992 Oct 31;78(5):353-5. doi: 10.1177/030089169207800515.
1992
AOU San Luigi di Orbassano
Berruti A; Gorzegno G; Vitetta G; Tampellini M; Dogliotti L;